BACKGROUND: Lp(a), implicated in both atherogenesis and thrombosis pathways, varies significantly by demographic and metabolic factors, providing challenges for its use in Coronary Heart Disease (CHD) risk. The purpose of this study was to investigate whether type-2 diabetic subjects, relative to non-diabetics, might benefit more from Lp(a) measurement in the prediction of CHD risk, as measured by coronary artery calcium (CAC). METHODS: We performed cross sectional analyses in two community-based studies: the Penn Diabetes Heart Study [N = 1299 with type-2 diabetes] and the Study of Inherited Risk of Coronary Atherosclerosis [N = 860 without diabetes]. RESULTS: Blacks had 2-3 fold higher Lp(a) levels than whites in diabetic and non-diabetic samples. There was significant difference by gender (interaction p<0.001), but not race, in the association of Lp(a) with CAC in type-2 diabetic subjects. In age and race adjusted analysis of diabetic women, Lp(a) was associated with CAC [Tobit regression ratio 2.76 (95% CI 1.73-4.40), p<0.001]. Adjustment for exercise, medications, Framingham risk score, metabolic syndrome, BMI, CRP and hemoglobin A1c attenuated this effect, but the association of Lp(a) with CAC remained significant [2.25, (1.34-3.79), p = 0.002]. This relationship was further maintained in women stratified by race, or by the use of HRT or lipid lowering drugs. In contrast, Lp(a) was not associated with CAC in diabetic men, nor in non-diabetic men and women. CONCLUSIONS: Lp(a) is a strong independent predictor of CAC in type-2 diabetic women, regardless of race, but not in men. Lp(a) does not relate to CAC in men or women without type-2 diabetes.
BACKGROUND:Lp(a), implicated in both atherogenesis and thrombosis pathways, varies significantly by demographic and metabolic factors, providing challenges for its use in Coronary Heart Disease (CHD) risk. The purpose of this study was to investigate whether type-2 diabetic subjects, relative to non-diabetics, might benefit more from Lp(a) measurement in the prediction of CHD risk, as measured by coronary artery calcium (CAC). METHODS: We performed cross sectional analyses in two community-based studies: the Penn Diabetes Heart Study [N = 1299 with type-2 diabetes] and the Study of Inherited Risk of Coronary Atherosclerosis [N = 860 without diabetes]. RESULTS: Blacks had 2-3 fold higher Lp(a) levels than whites in diabetic and non-diabetic samples. There was significant difference by gender (interaction p<0.001), but not race, in the association of Lp(a) with CAC in type-2 diabetic subjects. In age and race adjusted analysis of diabeticwomen, Lp(a) was associated with CAC [Tobit regression ratio 2.76 (95% CI 1.73-4.40), p<0.001]. Adjustment for exercise, medications, Framingham risk score, metabolic syndrome, BMI, CRP and hemoglobin A1c attenuated this effect, but the association of Lp(a) with CAC remained significant [2.25, (1.34-3.79), p = 0.002]. This relationship was further maintained in women stratified by race, or by the use of HRT or lipid lowering drugs. In contrast, Lp(a) was not associated with CAC in diabeticmen, nor in non-diabeticmen and women. CONCLUSIONS:Lp(a) is a strong independent predictor of CAC in type-2 diabeticwomen, regardless of race, but not in men. Lp(a) does not relate to CAC in men or women without type-2 diabetes.
Authors: Rudy Guerra; Zhaoxia Yu; Santica Marcovina; Ronald Peshock; Jonathan C Cohen; Helen H Hobbs Journal: Circulation Date: 2005-03-21 Impact factor: 29.690
Authors: Anna Bennet; Emanuele Di Angelantonio; Sebhat Erqou; Gudny Eiriksdottir; Gunnar Sigurdsson; Mark Woodward; Ann Rumley; Gordon D O Lowe; John Danesh; Vilmundur Gudnason Journal: Arch Intern Med Date: 2008-03-24
Authors: Atif Qasim; Nehal N Mehta; Mahlet G Tadesse; Megan L Wolfe; Thomas Rhodes; Cynthia Girman; Muredach P Reilly Journal: J Am Coll Cardiol Date: 2008-07-15 Impact factor: 24.094
Authors: Mark D Huffman; Namratha R Kandula; Abigail S Baldridge; Michael Y Tsai; Dorairaj Prabhakaran; Alka M Kanaya Journal: Am J Cardiol Date: 2018-12-19 Impact factor: 2.778
Authors: Atif N Qasim; Hashmi Rafeek; Suraj P Rasania; Timothy W Churchill; Wei Yang; Victor A Ferrari; Saurabh Jha; Stephen M Master; Claire K Mulvey; Karen Terembula; Chris Dailing; Matthew J Budoff; Steven M Kawut; Muredach P Reilly Journal: Atherosclerosis Date: 2012-12-05 Impact factor: 5.162
Authors: Brian T Steffen; George Thanassoulis; Daniel Duprez; James H Stein; Amy B Karger; Mathew C Tattersall; Joel D Kaufman; Weihua Guan; Michael Y Tsai Journal: Arterioscler Thromb Vasc Biol Date: 2019-03 Impact factor: 8.311
Authors: Young Hak Chung; Byoung-Kwon Lee; Hyuck Moon Kwon; Pil-Ki Min; Eui-Young Choi; Young Won Yoon; Bum-Kee Hong; Se-Joong Rim; Jong-Youn Kim Journal: Medicine (Baltimore) Date: 2021-03-05 Impact factor: 1.817